Last reviewed · How we verify
IDP-120 Gel
IDP-120 Gel is a topical retinoid formulation designed to treat acne and other skin conditions by promoting cell turnover and reducing sebum production.
IDP-120 Gel is a topical retinoid formulation designed to treat acne and other skin conditions by promoting cell turnover and reducing sebum production. Used for Acne vulgaris.
At a glance
| Generic name | IDP-120 Gel |
|---|---|
| Also known as | Component A + B, Gel |
| Sponsor | Bausch Health Americas, Inc. |
| Drug class | Retinoid |
| Target | Retinoid receptors (RAR/RXR) |
| Modality | Small molecule |
| Therapeutic area | Dermatology |
| Phase | Phase 3 |
Mechanism of action
IDP-120 Gel contains a retinoid active pharmaceutical ingredient delivered in a gel formulation for topical application. Retinoids work by binding to retinoid receptors in skin cells, promoting differentiation and reducing comedone formation. This mechanism helps normalize keratinization and reduce inflammatory acne lesions.
Approved indications
- Acne vulgaris
Common side effects
- Skin irritation
- Erythema
- Dryness
- Peeling
Key clinical trials
- Study Comparing the Safety and Efficacy of IDP-120 Gel and IDP-120 Vehicle Gel in the Treatment of Acne Vulgaris (PHASE3)
- Study Comparing the Safety and Efficacy of IDP-120 Gel and IDP-120 Vehicle Gel in the Treatment of Acne Vulgaris (PHASE3)
- Efficacy and Safety of IDP-120 Gel in the Treatment of Acne Vulgaris (PHASE2)
- Absorption and Systematic Pharmacokinetics of Topically Applied IDP-120 Gel (PHASE1)
- A Study Comparing the Efficacy and Safety of IDP-120 Gel in the Treatment of Acne Vulgaris (PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- IDP-120 Gel CI brief — competitive landscape report
- IDP-120 Gel updates RSS · CI watch RSS
- Bausch Health Americas, Inc. portfolio CI